ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,609.83
0.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Endo International PLC (ENDP)

  7. Endo International PLC (ENDP) News

Endo (ENDP)

Endo International PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENDP
DateTimeSourceHeadlineSymbolCompany
21/09/202312:45PR Newswire (Canada)Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual MeetingNASDAQ:ENDPEndo International PLC
21/09/202312:45PR Newswire (US)Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual MeetingNASDAQ:ENDPEndo International PLC
08/08/202312:45PR Newswire (US)ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
08/08/202312:45PR Newswire (Canada)ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
18/07/202321:30PR Newswire (US)Endo Launches Bivalirudin Injection in Ready-to-Use VialsNASDAQ:ENDPEndo International PLC
13/07/202321:30PR Newswire (US)Endo Presents New Data at the American Podiatric Medical Association Annual MeetingNASDAQ:ENDPEndo International PLC
29/06/202321:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
12/06/202312:30PR Newswire (US)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
12/06/202312:30PR Newswire (US)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
12/06/202312:30PR Newswire (Canada)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
08/05/202312:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
08/05/202312:30PR Newswire (US)ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
17/04/202312:45PR Newswire (US)Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label ProgramNASDAQ:ENDPEndo International PLC
03/04/202321:30PR Newswire (Canada)Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral SuspensionNASDAQ:ENDPEndo International PLC
03/04/202321:30PR Newswire (US)Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral SuspensionNASDAQ:ENDPEndo International PLC
13/03/202320:17PR Newswire (US)Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar FibromatosisNASDAQ:ENDPEndo International PLC
10/03/202312:30PR Newswire (US)Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) CapsulesNASDAQ:ENDPEndo International PLC
06/03/202321:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ENDPEndo International PLC
06/03/202314:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
06/03/202314:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
27/02/202322:15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
27/02/202322:10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
27/02/202322:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
27/02/202322:00Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ENDPEndo International PLC
14/02/202314:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
13/02/202317:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENDPEndo International PLC
06/02/202312:30PR Newswire (US)Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's DiseaseNASDAQ:ENDPEndo International PLC
31/01/202322:06Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ENDPEndo International PLC
22/12/202221:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
06/12/202221:45PR Newswire (US)Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)NASDAQ:ENDPEndo International PLC
 Showing the most relevant articles for your search:NASDAQ:ENDP

Your Recent History

BIT
P1YOD6
NLBNPIT1YOD6 20240920 1.7
BIT
P206N1
NLBNPIT206N1 20240920 12
BIT
UV8C76
UniCredit Bank
BIT
P1THY6
NLBNPIT1THY6 20240621 250
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved